Evaluation of tumor immune microenvironment for PD-L1 score and tumor infiltrating lymphocytes in high grade osteosarcomas and their correlation with disease progression. This is an ASCO Meeting ...
Ligand Pharmaceuticals LGND announced that it has signed an agreement to merge its subsidiary Pelican Technology Holdings, Inc., with Primordial Genetics to create a new stand-alone private company ...
A study of analyst recommendations at the major brokerages shows that Ligand Pharmaceuticals Inc (Symbol: LGND) is the #11 broker analyst pick among those stocks screened by The Online Investor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback